Gene · 771
Papers1,772
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 1,772
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An Investigation of the Antigastric Cancer Effect in Tumor Microenvironment of Radix Rhei Et Rhizome: A Network Pharmacology Study. | Evid Based Complement Alternat Med | 2021 | 34257692 | PubTator, text mining | PubMed |
| Expression of Glycolysis-Related Proteins in Cancer of Unknown Primary Origin. | Front Oncol | 2021 | 34249728 | PubTator, text mining | PubMed |
| CircCA12 Promotes Malignant Process via Sponging miR-1184 and Upregulating RAS Family in Bladder Cancer. | Front Genet | 2021 | 34234808 | PubTator, text mining | PubMed |
| Identification of the circRNA-miRNA-mRNA regulatory network and its prognostic effect in colorectal cancer. | World J Clin Cases | 2021 | 34222420 | PubTator, text mining | PubMed |
| Investigation of the protective effect of acetazolamide and SLC-0111 on carbon tetrachloride-induced toxicity in fruit fly. | Toxicol Rep | 2021 | 34221901 | PubTator, text mining | PubMed |
| Short- and Long-Lived Autoantibody-Secreting Cells in Autoimmune Neurological Disorders. | Front Immunol | 2021 | 34220839 | PubTator, text mining | PubMed |
| Differential gene expression identifies a transcriptional regulatory network involving ER-alpha and PITX1 in invasive epithelial ovarian cancer. | BMC Cancer | 2021 | 34215221 | PubTator, text mining | PubMed |
| Extracellular Vesicles: An Important Biomarker in Recurrent Pregnancy Loss? | J Clin Med | 2021 | 34207656 | PubTator, text mining | PubMed |
| Pharmacological Inhibition of CBP/p300 Blocks Estrogen Receptor Alpha (ERα) Function through Suppressing Enhancer H3K27 Acetylation in Luminal Breast Cancer. | Cancers (Basel) | 2021 | 34199844 | PubTator, text mining | PubMed |
| Expression Profiles of ASIC1/2 and TRPV1/4 in Common Skin Tumors. | Int J Mol Sci | 2021 | 34199609 | PubTator, text mining | PubMed |
| A Novel Inflammatory-Nutritional Prognostic Scoring System for Stage III Gastric Cancer Patients With Radical Gastrectomy Followed by Adjuvant Chemotherapy. | Front Oncol | 2021 | 34195071 | PubTator, text mining | PubMed |
| Thiazide and other Cl-benzenesulfonamide-bearing clinical drug affinities for human carbonic anhydrases. | PLoS One | 2021 | 34166457 | PubTator, text mining | PubMed |
Investigation of 3-sulfamoyl coumarins against cancer-related IX and XII isoforms of human carbonic anhydrase as well as cancer cells leads to the discovery of 2-oxo-2H-benzo[h]chromene-3-sulfonamide - A new caspase-activating proapoptotic agent. | Eur J Med Chem | 2021 | 34147910 | PubTator, text mining | PubMed |
| Gender specific airway gene expression in COPD sub-phenotypes supports a role of mitochondria and of different types of leukocytes. | Sci Rep | 2021 | 34145303 | PubTator, text mining | PubMed |
| Identification of Novel Therapeutic Targets for Fibrolamellar Carcinoma Using Patient-Derived Xenografts and Direct-from-Patient Screening. | Cancer Discov | 2021 | 34127480 | PubTator, text mining | PubMed |
| Analysis of the Efficacy and Mechanism of Action of Xuebijing Injection on ARDS Using Meta-Analysis and Network Pharmacology. | Biomed Res Int | 2021 | 34124260 | PubTator, text mining | PubMed |
| Interpreting the Molecular Mechanisms of Yinchenhao Decoction on Hepatocellular Carcinoma through Absorbed Components Based on Network Pharmacology. | Biomed Res Int | 2021 | 34104649 | PubTator, text mining | PubMed |
| Employing hypoxia characterization to predict tumour immune microenvironment, treatment sensitivity and prognosis in hepatocellular carcinoma. | Comput Struct Biotechnol J | 2021 | 34093992 | PubTator, text mining | PubMed |
| A case report of CLIPPERS syndrome and literature review. | Medicine (Baltimore) | 2021 | 34087853 | PubTator, text mining | PubMed |
| The Carbonic Anhydrase Inhibitor E7070 Sensitizes Glioblastoma Cells to Radio- and Chemotherapy and Reduces Tumor Growth. | Mol Neurobiol | 2021 | 34085182 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/771/papers?page=29